Evolucia Inc.

CIK:0001383006|SEC Filings

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Consolidated Statements of Operations
Sales	$ 61,114	$ 725,278	$ 1,204,093	$ 1,588,875
Cost of sales	(187,043)	563,542	691,367	1,284,777
Gross profit	248,157	161,736	512,726	304,098
Operating expenses:
Selling, general and administrative expenses	1,439,796	3,055,479	4,610,746	6,531,084
Loss from operations	$ (1,191,639)	(2,893,743)	$ (4,098,020)	$ (6,226,986)
Other income (expenses):
Other expense		18,529
Change in fair value of debt instruments, net		303,009	$ 487,761	$ 39,215
Interest expense and debt conversion expense, net	$ (406,367)	(860,588)	(546,464)	(2,663,386)
Total other income (expenses)	(406,367)	(539,050)	(58,703)	(2,624,171)
Loss before income taxes	$ (1,598,006)	$ (3,432,793)	$ (4,156,723)	$ (8,851,157)
Income taxes
Net loss	$ (1,598,006)	$ (3,432,793)	$ (4,156,723)	$ (8,851,157)
Per share information basic and diluted:
Loss per share, basic and diluted (in Dollars per share)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Weighted average shares outstanding (in Shares)	1,355,269,085	1,237,422,713	1,342,571,858	1,216,154,683

Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended		12 Months Ended	21 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Sep. 30, 2014
Cash flows from operating activities:
Net cash (used in) operating activities	$ (925,919)	$ (4,856,080)
Cash flows from investing activities:
Acquisition of property and equipment	(77,585)	(188,864)
Net cash (used in) investing activities	(77,585)	$ (188,864)
Cash flows from financing activities:
Proceeds (repayments) of loan from affiliates	897,500
Proceeds from lines of credit, net	1,858
Proceeds from notes payable and convertible debentures	95,000	$ 3,446,814
Net cash provided by financing activities	994,358	3,446,814
Increase (decrease) in cash and cash equivalents	(9,146)	(1,598,130)
Cash and cash equivalents, beginning	16,120	1,642,464	$ 1,642,464	$ 1,642,464
Cash and cash equivalents, ending	6,974	44,334	$ 16,120	$ 6,974
Supplemental cash flow information:
Cash paid for interest	$ 12,120	$ 72,828
Cash paid for income taxes

Consolidated Balance Sheets - USD ($)	Sep. 30, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 6,974	$ 16,120
Accounts receivable, net	548,195	338,361
Inventory	554,891	732,145
Prepaid expenses and other current assets	10,437	38,198
Total current assets	1,120,497	1,124,824
Property and equipment, at cost, net of accumulated depreciation of $66,968 and $126,719	74,062	137,395
Other assets:
Deposits and other assets	75,218	89,013
Total assets	1,269,777	1,351,232
Current liabilities:
Accounts payable and accruals	$ 3,538,485	2,843,402
Convertible notes payable		50,000
Share repurchase liability	$ 1,000,000	1,000,000
Liability for over commitment of common shares	230,000	840,000
Current portion of notes payable	936,474	664,642
Total current liabilities	5,704,959	5,398,044
Derivative liabilities	136,890	1,305,298
Convertible notes payable, long term portion, net of debt discount	1,963,553	450,000
Notes payable, long term portion, net of debt discount	2,529,409	1,344,431
Lines of credit, affiliates, long term portion	2,659,810	2,757,952
Total liabilities	$ 12,994,621	$ 11,255,725
Commitments and contingencies
Stockholders' equity (deficit):
Common stock, $0.001 par value, 1,500,000,000 shares authorized, 1,355,269,085 and 1,266,457,952 shares issued and outstanding	$ 1,355,269	$ 1,266,458
Additional paid-in capital	93,170,303	90,922,742
Accumulated (deficit)	(106,215,941)	(102,059,218)
Stockholders' equity before treasury stock	(11,690,369)	(9,870,018)
Less: Treasury stock, at cost, 313,400 shares	(34,475)	(34,475)
Stockholders' equity	(11,724,844)	(9,904,493)
Total Liabilities and Stockholders' equity	$ 1,269,777	$ 1,351,232